ACFN vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 18, 2026

ACFN

73.6
AI Score
VS
ACFN Wins

MLAB

38.6
AI Score

Investment Advisor Scores

ACFN

74score
Recommendation
BUY

MLAB

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACFN MLAB Winner
Revenue 4.72M 60.14M MLAB
Net Income 217,000 2.83M MLAB
Gross Margin 81.3% 64.9% ACFN
Net Margin 4.6% 4.7% MLAB
Operating Income 246,000 7.03M MLAB
ROE 2.5% 1.5% ACFN
ROA 1.6% 0.7% ACFN
Total Assets 13.39M 419.22M MLAB
Cash 4.48M 30.70M MLAB
Current Ratio 2.12 1.79 ACFN

Relative Price Performance (Last 90 Days)

ACFN 1M: -14.0% · 3M: -8.5% MLAB 1M: -3.7% · 3M: +26.7%

Current Technical Phase

ACFN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 41

RSI (14): 41.0 · Price: $18.33

MLAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $122.48

Fundamentals Snapshot

Metric ACFN MLAB
Market Cap — —
Forward P/E 98.0 22.7
Trailing P/E 30.7 150.3
Revenue (TTM) — —
Revenue Growth -0.3% 0.0%
Gross Margin 0.8% 0.6%
Operating Margin 0.2% 0.1%
EPS 0.61 0.85
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, ACFN is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.